Richard S. Judson
Directeur Technique/Scientifique/R&D chez Genaissance Pharmaceuticals, Inc.
Profil
Richard S.
Judson has been Senior Vice President and Chief Scientific Officer of Genaissance Pharmaceuticals, Inc. since September 2003.
He was Senior Vice President of Informatics for Genaissance Pharmaceuticals from April 2000 to August 2002.
Prior to joining Genaissance Pharmaceuticals in February 1999, he was Group Leader in the Bioinformatics Department of CuraGen Corp.
from January 1997 to February 1999.
Dr. Judson received a BA degree from Rice University and an MA as well as a PhD from Princeton University.
Postes actifs de Richard S. Judson
| Sociétés | Poste | Début |
|---|---|---|
Genaissance Pharmaceuticals, Inc.
 Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT. | Directeur Technique/Scientifique/R&D | 01/02/1999 |
Anciens postes connus de Richard S. Judson
| Sociétés | Poste | Fin |
|---|---|---|
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Corporate Officer/Principal | 01/02/1999 |
Formation de Richard S. Judson
| Rice University | Undergraduate Degree |
| Princeton University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Genaissance Pharmaceuticals, Inc.
Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT. | Health Technology |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Health Technology |
